ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Oxytocin, glu(4)-
C43H65N11O13S2
1008.2 g/mol
APIWarning

Oxytocin, glu(4)-

CAS4314-67-4
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

Oxytocin, glu(4)- is a modified analog of the neurohypophysial hormone oxytocin, where the glutamic acid residue at position 4 has been altered. It functions as a pharmaceutical raw material used in the manufacturing of research compounds for studying neurohypophysial hormone pathways.

pharmaceutical raw material for neurohypophysial hormone analog researchlaboratory reagent for oxytocin-related studies

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Oxytocin, glu(4)-?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongStructure SimilarSimilarity 0.92

5-Asp-oxytocin

CAS65907-78-0

pharmaceutical intermediate

StrongStructure SimilarSimilarity 0.92

Oxytocin free acid

CAS24346-32-5

research compound

StrongStructure SimilarSimilarity 0.92

Oxytocin (free acid)

CAS4248-64-0

pharmaceutical raw material

StrongStructure SimilarSimilarity 0.88

Urofollitropin

CAS97048-13-0

pharmaceutical raw material

ReferenceSame Category

4-Epiminocycline

CAS43168-51-0

pharmaceutical raw material

ReferenceSame Category

Allylestrenol

CAS432-60-0

pharmaceutical raw material

ReferenceSame Category

Arginine glutamate

CAS4320-30-3

pharmaceutical raw material

ReferenceSame Category

Zopiclone

CAS43200-80-2

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Health Hazard
Health Hazard
Warning
H361Suspected of damaging fertility or the unborn child
Identifiers
IUPAC Name

3-[(4R,7S,10S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-4-[(2S)-2-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-10-yl]propanoic acid

InChIKey

ANHHFWYHJRAVNA-OMTOYRQASA-N

SMILES

CC[C@H](C)C1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)O

Synonyms (7)
  • 4-Glu-oxytocin
  • Oxytocin, 4-L-glutamic acid-
  • Oxytocin, glu(4)-
  • Oxytocin, glutamic acid(4)-

Sourcing Oxytocin, glu(4)-?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→